These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug targeting by solid lipid nanoparticles for dermal use. Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M. J Drug Target; 2002 Sep; 10(6):489-95. PubMed ID: 12575739 [Abstract] [Full Text] [Related]
7. Reconstructed epidermis versus human and animal skin in skin absorption studies. Schreiber S, Mahmoud A, Vuia A, Rübbelke MK, Schmidt E, Schaller M, Kandárová H, Haberland A, Schäfer UF, Bock U, Korting HC, Liebsch M, Schäfer-Korting M. Toxicol In Vitro; 2005 Sep; 19(6):813-22. PubMed ID: 15913948 [Abstract] [Full Text] [Related]
8. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use. Lombardi Borgia S, Schlupp P, Mehnert W, Schäfer-Korting M. Eur J Pharm Biopharm; 2008 Feb; 68(2):380-9. PubMed ID: 17574402 [Abstract] [Full Text] [Related]
9. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids. Schlupp P, Blaschke T, Kramer KD, Höltje HD, Mehnert W, Schäfer-Korting M. Skin Pharmacol Physiol; 2011 Feb; 24(4):199-209. PubMed ID: 21346400 [Abstract] [Full Text] [Related]
10. Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate. Bätz FM, Klipper W, Korting HC, Henkler F, Landsiedel R, Luch A, von Fritschen U, Weindl G, Schäfer-Korting M. Eur J Pharm Biopharm; 2013 Jun; 84(2):374-85. PubMed ID: 23201050 [Abstract] [Full Text] [Related]
12. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Gysler A, Lange K, Korting HC, Schäfer-Korting M. Pharm Res; 1997 Jun; 14(6):793-7. PubMed ID: 9210199 [Abstract] [Full Text] [Related]
13. The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. Schäfer-Korting M, Bock U, Diembeck W, Düsing HJ, Gamer A, Haltner-Ukomadu E, Hoffmann C, Kaca M, Kamp H, Kersen S, Kietzmann M, Korting HC, Krächter HU, Lehr CM, Liebsch M, Mehling A, Müller-Goymann C, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Spielmann H, Vuia A, Weimer M. Altern Lab Anim; 2008 May; 36(2):161-87. PubMed ID: 18522484 [Abstract] [Full Text] [Related]
14. Cutaneous estradiol permeation, penetration and metabolism in pig and man. Mahmoud A, Haberland A, Dürrfeld M, Heydeck D, Wagner S, Schafer-Korting M. Skin Pharmacol Physiol; 2005 May; 18(1):27-35. PubMed ID: 15608500 [Abstract] [Full Text] [Related]
15. Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration. Barth J, Lehr KH, Derendorf H, Möllmann HW, Höhler T, Hochhaus G. Skin Pharmacol; 1993 May; 6(3):179-86. PubMed ID: 8274287 [Abstract] [Full Text] [Related]